Researchers find that blocking specific proteins in immune cells can reduce or reverse lung scarring
A discovery at Duke-NUS Medical School offers new hope in the battle against pulmonary fibrosis, a debilitating lung ...
emjreviews.com6h
New Research in Pulmonary Fibrosis Could Reverse Lung Scarring
Researchers have identified YAP and TAZ as crucial regulators of macrophage-mediated pulmonary inflammation and fibrosis, ...
EurekAlert!3d
Duke-NUS study targets proteins to reverse lung scarring
A discovery at Duke-NUS Medical School offers new hope in the battle against pulmonary fibrosis, a debilitating lung condition that progressively makes it harder for patients to breathe. Scientists ...
pulmonaryfibrosisnews18h
Runx2 protein may be treatment target for pulmonary fibrosis
A protein called Runx2 contributes to the abnormal activity of lung cells that drive pulmonary fibrosis, a new study shows.
pulmonaryfibrosisnews7d
Nerandomilast shows promise for progressive pulmonary fibrosis
Nerandomilast worked better than a placebo to preserve lung function in adults with progressive pulmonary fibrosis in a Phase ...
Yahoo Finance12d
Pliant Therapeutics Pauses Lead Product Mid-Stage Trial In Patients With Stiff Lung Tissues
Pliant Therapeutics announced it has voluntarily paused enrollment and dosing in the ongoing BEACON-IPF Phase 2b trial of ...
pharmaphorum12d
Pliant slumps on decision to pause lung disease drug trial
The drug is a dual-selective inhibitor of αvβ6 and αvβ1 integrins, which are seen in elevated levels in the lung tissue of IPF patients and are thought to promote fibrosis (scarring ...